載入...
A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration
BACKGROUND: There is a dearth of patient, preference-based cost-effectiveness analyses evaluating genetic testing for neovascular age-related macular degeneration (NVAMD). METHODS: A Value-Based Medicine, 12-year, combined-eye model, cost-utility analysis evaluated genetic testing of Category 3 AMD...
Na minha lista:
| 發表在: | Int J Retina Vitreous |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5088478/ https://ncbi.nlm.nih.gov/pubmed/27847612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-015-0016-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|